Archive — US — techcrunch
Israel’s famed VC Jon Medved, diagnosed with ALS, backed the tech that willimprove his life
Jon Medved, a prominent Israeli VC and founder of OurCrowd, has been diagnosed with ALS, prompting his retirement from the firm. He plans to utilize health tech investments he made to improve his quality of life, including an avatar system allowing him to communicate as his condition progresses. Medved remains hopeful to contribute to the startup ecosystem despite this challenging diagnosis.
Key points
- Jon Medved announced his retirement after being diagnosed with ALS, a condition that causes muscle control loss.
- He founded OurCrowd, which pioneered crowdsourced venture capital, allowing broader investor participation.
- Despite the diagnosis, Medved will leverage health tech innovations to enhance his living conditions, including voice-preserving avatars.
- Israel's startup ecosystem continues to thrive with significant investments despite ongoing conflicts, achieving nearly 100 unicorns and substantial venture capital funding.
Why it matters
- The rise of health tech is linked to the increasing prevalence of chronic illnesses and the demand for innovative healthcare solutions.
- Medved's focus on health tech highlights a growing trend in venture capital investments towards medical technologies driven by personal necessity.
- Israel's reputation as a 'Startup Nation' reflects its long-standing role in global tech innovation, particularly in fields like AI and biotech.
Jon Medved’s journey from venture capital to developing health tech tools for ALS illustrates the intersection of personal experience and technological innovation, reinforcing the importance of adaptive solutions in the face of illness.